Related Experiment Video
Updated: Jul 25, 2026

Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
Long-Term Observation of Orbital Development in Patients With Retinoblastoma Following Unilateral Enucleation
Background:
This study aims to investigate bilateral orbital development differences and influencing factors in retinoblastoma patients undergoing unilateral enucleation.
Methods:
A retrospective comparative analysis was performed on patients from Beijing Tongren Hospital (January 2011-December 2020). Preoperative and 3 months, 1 year, 3 years postoperative, and the final follow-up imaging data were collected, with bilateral orbital volumes reconstructed using ITK-SNAP software.
Results:
Thirty-nine patients were followed for an average of 7.7 ± 2.45 years. Average orbital volumes (mm3) for the surgical and nonsurgical sides before surgery were 14,323.81 ± 4596.60 and 14,457.93 ± 4732.26 (p = 0.330). Postoperative volumes at 3 months were 16,481.84 ± 4034.21 and 16,866.45 ± 3999.71 (p = 0.007). At 12 months, volumes were 16,798.16 ± 3323.33 and 18,119.16 ± 3840.27 (p = 0.000). At 36 months, volumes were 18,758.26 ± 2917.35 and 19,973.55 ± 3189.83 (p = 0.000). The last follow-up volumes were 20,523.78 ± 3221.20 and 21,576.78 ± 3381.96 (p = 0.000). Bilateral volume differences were 2.28%, 7.29%, 6.08%, and 4.88% at 3 months, 12 months, 36 months after operation, and final follow-up. The growth trajectory on the surgical side demonstrated growth restrictions, accompanied by a shift in the growth peak. Factors affecting development included the age at the time of operation and the type of orbital implants.
Conclusions:
Volumetric analysis revealed active orbital development between 3 and 12 months post-enucleation, followed by a significant plateau phase. The final orbital volume deficit in the surgical orbit stabilized at approximately 5% compared to the non-operated orbit. Hydrogel implants demonstrated a trade-off: potentially reduced volume deficit but higher complication risks.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers

